OncoTest Teva - 20.6.2016

לפניכם הרצאות המפגש שהתקיים ב-20.6.2016 ב-RiverSide תל אביב

לתכנית לחצו כאן

Lior Soussan-GutmanGreetings & Opening Remarks

Dr. Lior Soussan-Gutman

Ph.D., Managing Director ONCOTEST-TEVA

 

 


Rick Lanman, MD
Non-Invasive and Comprehensive Identification of NCCN Genomic Targets for Matched Therapy with Cell-Free DNA

Rick Lanman, MD,

Chief Medical Officer, Guardant360

 

 


Nir Peled, MDLung Cancer Liquid Tumor Board

Nir Peled, MD,

Davidoff Medical Center

 

 


Hovav Nechushtan, MD, PhDLung Cancer Liquid Tumor Board

Hovav Nechushtan, MD, PhD,

Hadassah Medical Center

 

 


Deborah T. Blumenthal, MDLung Cancer Liquid Tumor Board

Deborah T. Blumenthal, MD,

Souraski Medical center

 

 


Elizabeth Dudnik, MDLung Cancer Liquid Tumor Board

Double Primary Tumors: an additional value of a liquid biopsy

Elizabeth Dudnik, MD

Davidoff Medical Center

 


Lung Cancer Liquid Tumor Board

Panel

Rick Lanman, MD, Nir Peled, MD, Hovav Nechushtan, MD, PhD, Elizabeth Dudnik, MD,
Deborah T. Blumenthal, MD, , Dov Hershkovitz, MD, PhD


Tamar Yablonski-Peretz, MDBreast Cancer Liquid Tumor Board

Tamar Yablonski-Peretz, MD,

Hadassah Medical Center

 

 


Noa Efrat Ben-Baruch, MDBreast Cancer Liquid Tumor Board

Noa Efrat Ben-Baruch, MD,

Kaplan Medical Center

 

 


Shulamith Rizel, MD,Breast Cancer Liquid Tumor Board

Shulamith Rizel, MD,

Davidoff Medical Center

 

 


Breast Cancer Liquid Tumor Board

Panel

Rick Lanman, MD, Tamar Yablonski-Peretz, MD, Noa Efrat Ben-Baruch, MD, Shulamith Rizel, MD,


Irit Ben AharonGI Cancer Liquid Tumor Board

Case presentation: Cholangiocarcinoma


Irit Ben Aharon, MD, PhD,
Davidoff Medical Center

 


Talia Golan, MD,GI Cancer Liquid Tumor Board

Talia Golan, MD,
Sheba Medical Center

 

 


Eyal FenigGU Cancer Liquid Tumor Board

Eyal Fenig, MD,
Davidoff Medical Center


 





e-Med ערוץ החדשות הרפואיות של ישראל